Today Vimian Group signed an agreement to acquire Bova Holdings Limited (Bova), a leading companion animal health specialty pharmaceuticals company in the United Kingdom. The company offers customised specialty pharmaceuticals for companion animals.
Established in 2017, Bova offers specialty pharmaceuticals covering a wide and expanding range of product classes. The company has more than 100 specialty pharmaceutical formulations, all raw materials and products are compliant with quality standards set out by regulatory authorities and the pharmaceuticals industry. Bova serves veterinary clinics and hospitals across the UK and in ten additional European markets through an online ordering system with deliveries within 24 hours.
Nick Bova, founder and CEO of Bova, will continue to lead the company as part of Nextmune and Vimian.
Vegner Group Limited is a leading residential property management group in the UK with 475 employees, over 100,000 homes under management and a nationwide reach across 20 office locations. Vegner specializes in serving Residents Management Company (RMC) clients, bringing further
Read moreFidelio Capital acquires 10 million shares, around 2.2 percent of the capital, in the animal health company Vimian Group AB, effective 21 September 2023. Through the transaction, Fidelio will increase its ownership in Vimian, from 53 percent of the capital
Read moreOdevo, an international leader that is driving change in the traditional property management industry, continues its rapid expansion in the US market with the addition of the leading property manager in the Carolinas, William Douglas Management. William Douglas manages over
Read more